Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 21, 2018
[Clinical and serological diversity in systemic sclerosis]Ewa Wielosz, Maria MajdanReumatologia|July 21, 2020
Haematological abnormalities in systemic sclerosisEwa Wielosz, Maria MajdanWiadomosci Lekarskie (Warsaw, Poland : 1960)|August 8, 2020
Clinical and serological parameters of progression and prognosis in patients with systemic sclerosis - a state of the art reviewEwa Wielosz, Maria MajdanClinical Rheumatology|May 14, 2009
Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanReumatologia|June 1, 2022
Methods of assessment of joint involvement in various systemic connective tissue diseasesTobiasz Kardas, Ewa Wielosz, Maria MajdanPostepy Dermatologii I Alergologii|February 19, 2021
Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanAnnales Academiae Medicae Stetinensis|March 4, 2011
[Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil]Dorota Suszek, Ewa Wielosz, Maria MajdanPostepy Higieny I Medycyny Doswiadczalnej (Online)|September 18, 2014
Serological profile of patients with systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanAnnals of Agricultural and Environmental Medicine : AAEM|March 29, 2021
The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanPostepy Dermatologii I Alergologii|July 19, 2024
The usefulness of nailfold capillaroscopy in scleroderma-spectrum disorders: a single-centre observational studyKatarzyna Wiąk-Walerowicz, Ewa Wielosz, Maria MajdanPageof 16